A variant typical of the Finnish population that protects against heart diseases was identified in the FinnGen genomic study coordinated by the University of Helsinki. The risk of developing heart diseases is roughly one-fifth lower in carriers of the variant compared to the population on average.
GeneRISK study shows that information about personal genetic risk for cardiovascular disease motivates individuals to take better care of their health. This is the first comprehensive study assessing the impact of overall disease risk information based on both genetic and traditional health factors on lifestyle.
An international consortium of leading migraine scientists identified more than 120 regions of the genome that are connected to risk of migraine. The groundbreaking study helps researchers better understand the biological basis of migraine and its subtypes and can speed up the search for new treatment of the condition.
New results from the FinnGen study demonstrate the undeniable benefits of Finnish health research environment for genomic research.
A new study from the University of Helsinki demonstrates the added value of genetic information in measuring inherited disease risk, alongside the widely used assessment of family history.
The study, led by the University of Helsinki, identified seven previously novel genetic risk factors for idiopathic pulmonary fibrosis.